Valuation: Baxter International Inc.

Capitalization 1.47TCr 1.26TCr 1.17TCr 1.09TCr 2.02TCr 1,26300Cr 2.24TCr 14TCr 5.37TCr 59TCr 5.52TCr 5.41TCr 2,16900Cr P/E ratio 2025 *
23.7x
P/E ratio 2026 * 19.8x
Enterprise value 2.23TCr 1.9TCr 1.77TCr 1.65TCr 3.05TCr 1,91100Cr 3.39TCr 21TCr 8.13TCr 89TCr 8.36TCr 8.18TCr 3,28300Cr EV / Sales 2025 *
1.96x
EV / Sales 2026 * 1.81x
Free-Float
74.36%
Yield 2025 *
2.41%
Yield 2026 * 2.55%
More valuation ratios * Estimated data
Dynamic Chart
1 day-3.37%
1 week-7.45%
Current month-5.22%
1 month-6.27%
3 months+3.09%
6 months-5.90%
Current year-1.58%
More quotes
1 week 28.5
Extreme 28.505
31.15
1 month 28.5
Extreme 28.505
31.76
Current year 26.25
Extreme 26.25
37.74
1 year 26.25
Extreme 26.25
40.49
3 years 26.25
Extreme 26.25
67.06
5 years 26.25
Extreme 26.25
91.45
10 years 26.25
Extreme 26.25
95.19
More quotes
Manager TitleAgeSince
Chief Executive Officer 67 03/02/2025
Director of Finance/CFO 55 18/10/2023
Chief Operating Officer 53 03/02/2025
Director TitleAgeSince
Director/Board Member 74 06/02/2017
Director/Board Member 61 18/07/2017
Director/Board Member 65 18/02/2019
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-3.37%-7.45%-18.74%-55.00% 1.47TCr
-1.18%-1.80%+26.67%+24.30% 23TCr
+0.58%+1.73%+15.36%+2.29% 12TCr
-0.71%-0.34%+32.62%+112.21% 5.72TCr
-0.86%-0.11%-23.19%-25.27% 5.04TCr
+1.85%+9.82%-10.71%+43.18% 4.15TCr
-2.45%+0.53%-26.91%+9.19% 3.27TCr
-0.61%-0.18%-11.36%+13.66% 2.46TCr
-3.19%-1.50%+17.56%-40.75% 2.32TCr
-1.17%-4.01%+2.85%+11.01% 2.24TCr
Average -0.75%-0.51%+0.41%+9.48% 6.12TCr
Weighted average by Cap. -0.56%-0.24%+11.74%+19.48%
See all sector performances

Financials

2025 *2026 *
Net sales 1.14TCr 972.94Cr 906.26Cr 842.91Cr 1.56TCr 98TCr 1.73TCr 11TCr 4.15TCr 46TCr 4.27TCr 4.18TCr 1,67700Cr 1.19TCr 1.01TCr 944.2Cr 878.2Cr 1.62TCr 1,01700Cr 1.8TCr 11TCr 4.33TCr 48TCr 4.45TCr 4.35TCr 1,74700Cr
Net income 59Cr 50Cr 47Cr 43Cr 80Cr 5.03TCr 89Cr 559.02Cr 213.74Cr 2.35TCr 219.68Cr 215.15Cr 8.63TCr 72Cr 62Cr 57Cr 53Cr 99Cr 6.19TCr 109.67Cr 688.03Cr 263.06Cr 2.9TCr 270.38Cr 264.81Cr 11TCr
Net Debt 755.48Cr 646.01Cr 601.74Cr 559.67Cr 1.03TCr 65TCr 1.15TCr 7.21TCr 2.76TCr 30TCr 2.83TCr 2.78TCr 1,11300Cr 674.99Cr 577.19Cr 537.63Cr 500.05Cr 923.95Cr 58TCr 1.03TCr 6.44TCr 2.46TCr 27TCr 2.53TCr 2.48TCr 99TCr
More financial data * Estimated data
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - medicines and medical devices (33.8%): products intended for treating hemophilia (substitution clotting factors) and immune deficiencies (multi-purpose immunoglobins), and used in intensive care (human albumin) and biosurgery (fibrin adhesive, surgical gel, bone substitutes, hemostatic compresses, etc.); - kidney dialysis drugs and equipment (30.1%); - systems for delivering medications and intravenous therapy (15.2%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, etc.; - other (20.1%). Export accounts for 52.7% of net sales.
Employees
38,000
More about the company
Date Price Change Volume
11/25/11 28.70 $ -3.37% 68,05,855
10/25/10 29.70 $ -0.37% 65,49,964
09/25/09 29.81 $ -2.77% 71,64,975
08/25/08 30.66 $ +3.27% 62,98,003

Delayed Quote Nyse, July 12, 2025 at 01:30 am IST

More quotes
Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
28.70USD
Average target price
38.09USD
Spread / Average Target
+32.73%
Consensus

Quarterly revenue - Rate of surprise